Long-term, Low-Dose Oral Azithromycin Treatment for Chronic Severe Bilateral Blepharokeratoconjunctivitis in Pediatric Patients.

IF 1 4区 医学 Q4 OPHTHALMOLOGY Journal of Pediatric Ophthalmology & Strabismus Pub Date : 2024-09-01 Epub Date: 2024-05-30 DOI:10.3928/01913913-20240508-06
Esin Sogutlu Sari, Ahmet Tuncer Ozmen, Meral Yildiz, Berna Akova, Mehmet Baykara, Shole Hasanova
{"title":"Long-term, Low-Dose Oral Azithromycin Treatment for Chronic Severe Bilateral Blepharokeratoconjunctivitis in Pediatric Patients.","authors":"Esin Sogutlu Sari, Ahmet Tuncer Ozmen, Meral Yildiz, Berna Akova, Mehmet Baykara, Shole Hasanova","doi":"10.3928/01913913-20240508-06","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the efficacy and safety of oral azithromycin treatment combined with topical antibiotic and anti-inflammatory agents in pediatric patients with chronic severe bilateral blepharokeratoconjunctivitis.</p><p><strong>Methods: </strong>Patients younger than 14 years with chronic and severe bilateral blepharokeratoconjunctivitis were reviewed retrospectively. Consecutive patients receiving oral azithromycin treatment were included. All patients received oral azithromycin (5 mg/kg/single dose daily) for at least 4 weeks combined with topical antibiotic and anti-inflammatory agents. Before and after the treatment, clinical symptoms were noted, and corneal and conjunctival fluorescein staining and corneal neovascularization were graded. Meibomian gland secretion and meibomian gland plugging were also assessed. All patients completed at least 3 months of follow-up after completion of the oral azithromycin treatment. Patients' clinical data at the time of diagnosis and last follow-up visit were statistically compared.</p><p><strong>Results: </strong>Twenty-nine children (58 eyes, mean age of 6.51 years) were included. The mean time of oral azithromycin use was 5.87 weeks (range: 4 to 10 weeks). Clinical symptoms and signs and visual acuity were significantly improved after treatment. The mean fluorescein staining and corneal neovascularization grades and meibomian gland secretion and meibomian gland plugging scores also improved after treatment (<i>P</i> < .001). Eyelid distortion or fornix shortening was not observed. At the last follow-up visit, all patients were stable with treatment only with daily eyelid hygiene, topical cyclosporine, and artificial tears.</p><p><strong>Conclusions: </strong>Long-term, low-dose oral azithromycin combined with topical antibiotic and anti-inflammatory agents is an effective treatment option for pediatric patients with chronic severe bilateral blepharokeratoconjunctivitis. <b>[<i>J Pediatr Ophthalmol Strabismus</i>. 2024;61(5):358-364.]</b>.</p>","PeriodicalId":50095,"journal":{"name":"Journal of Pediatric Ophthalmology & Strabismus","volume":" ","pages":"358-364"},"PeriodicalIF":1.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Ophthalmology & Strabismus","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3928/01913913-20240508-06","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To evaluate the efficacy and safety of oral azithromycin treatment combined with topical antibiotic and anti-inflammatory agents in pediatric patients with chronic severe bilateral blepharokeratoconjunctivitis.

Methods: Patients younger than 14 years with chronic and severe bilateral blepharokeratoconjunctivitis were reviewed retrospectively. Consecutive patients receiving oral azithromycin treatment were included. All patients received oral azithromycin (5 mg/kg/single dose daily) for at least 4 weeks combined with topical antibiotic and anti-inflammatory agents. Before and after the treatment, clinical symptoms were noted, and corneal and conjunctival fluorescein staining and corneal neovascularization were graded. Meibomian gland secretion and meibomian gland plugging were also assessed. All patients completed at least 3 months of follow-up after completion of the oral azithromycin treatment. Patients' clinical data at the time of diagnosis and last follow-up visit were statistically compared.

Results: Twenty-nine children (58 eyes, mean age of 6.51 years) were included. The mean time of oral azithromycin use was 5.87 weeks (range: 4 to 10 weeks). Clinical symptoms and signs and visual acuity were significantly improved after treatment. The mean fluorescein staining and corneal neovascularization grades and meibomian gland secretion and meibomian gland plugging scores also improved after treatment (P < .001). Eyelid distortion or fornix shortening was not observed. At the last follow-up visit, all patients were stable with treatment only with daily eyelid hygiene, topical cyclosporine, and artificial tears.

Conclusions: Long-term, low-dose oral azithromycin combined with topical antibiotic and anti-inflammatory agents is an effective treatment option for pediatric patients with chronic severe bilateral blepharokeratoconjunctivitis. [J Pediatr Ophthalmol Strabismus. 2024;61(5):358-364.].

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
长期小剂量口服阿奇霉素治疗小儿慢性严重双侧眼睑角化性结膜炎。
目的:评估口服阿奇霉素联合外用抗生素和消炎药治疗慢性重度双侧睑角结膜炎儿童患者的有效性和安全性:对14岁以下患有慢性严重双侧眼睑角化性结膜炎的患者进行回顾性研究。纳入连续接受阿奇霉素口服治疗的患者。所有患者均接受了至少 4 周的阿奇霉素口服治疗(5 毫克/千克/每日单剂量),并同时使用了局部抗生素和消炎药。治疗前后记录临床症状,并对角膜和结膜荧光素染色及角膜新生血管进行分级。此外,还对睑板腺分泌和睑板腺堵塞情况进行了评估。所有患者在完成阿奇霉素口服治疗后都接受了至少 3 个月的随访。对患者确诊时和最后一次随访时的临床数据进行了统计比较:共纳入 29 名儿童(58 只眼睛,平均年龄为 6.51 岁)。口服阿奇霉素的平均时间为 5.87 周(范围:4 至 10 周)。治疗后,临床症状和体征以及视力均有明显改善。平均荧光素染色和角膜新生血管等级以及睑板腺分泌和睑板腺堵塞评分在治疗后也有所改善(P < .001)。未观察到眼睑变形或穹窿缩短。在最后一次随访时,所有患者的病情都很稳定,只需每天进行眼睑卫生、外用环孢素和人工泪液治疗即可:结论:长期小剂量口服阿奇霉素联合外用抗生素和消炎药是治疗慢性严重双侧睑角结膜炎儿童患者的有效方法。[J Pediatr Ophthalmol Strabismus.
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.80
自引率
8.30%
发文量
115
审稿时长
>12 weeks
期刊介绍: The Journal of Pediatric Ophthalmology & Strabismus is a bimonthly peer-reviewed publication for pediatric ophthalmologists. The Journal has published original articles on the diagnosis, treatment, and prevention of eye disorders in the pediatric age group and the treatment of strabismus in all age groups for over 50 years.
期刊最新文献
Changes in PAX7 Positive Satellite Cells in Extraocular Muscle After Strabismus Surgery. Long-term Motor and Sensory Outcomes After Unilateral Lateral Rectus Recession-Medial Rectus Resection for Infantile Constant Exotropia. Ophthalmic Outcomes in Children With Spina Bifida Myelomeningocele in Ireland. Capturing Bilateral Retinoblastoma. Botulinum Toxin A Augmentation of Strabismus Surgery for Large-Angle Strabismus: A Retrospective Case Series and Literature Review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1